Protagen signs collaboration with QIAGEN to develop novel protein-based companion diagnostics for autoimmune therapies
Protagen AG has recently entered into a long-term collaboration agreement with QIAGEN targeting the development of novel protein-based companion diagnostics for autoimmune disorders. Under the terms of the agreement, QIAGEN will gain access to the proprietary SeroTag technology platform of Protagen, which enables the discovery and validation of novel protein-based marker panels. Such markers hold […]
